« Back
Home /
Eptifibatide acetate

Eptifibatide acetate

Item no.	DCC-DC31679-100mg
Manufacturer	DCChemicals
CASRN	1248559-53-6
Amount	100 mg
Quantity options	100 mg 1 g 250 mg
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Smiles	NC(NCCCC[C@@H]1NC(CCSSC[C@@H](C(N)=O)NC([C@@H]2CCCN2C([C@@H](NC([C@@H](NC(CNC1=O)=O)CC(O)=O)=O)Cc(c[nH]3)c4c3cccc4)=O)=O)=O)=N
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Available
Manufacturer - Applications	Eptifibatide, also co-promoted by Schering-Plough/Essex, is an antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class. Eptifibatide is a cyclic heptapeptide derived from a protein found in the venom of the southeastern pygmy rattlesnake (Sistrurus miliarius barbouri). It belongs to the class of the arginin-glycin-aspartat-mimetics and reversibly binds to platelets. Eptifibatide has a short half-life. The drug is the third inhibitor of GPIIb/IIIa that has found broad acceptance after the specific antibody abciximab and the non-peptide tirofiban entered the global market.
Molecular Weight	892, 01

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 100 mg

available

Delivery expected until 8/7/2025

Express Delivery: Save 6 days

Compare

Add to wishlist

Recommend by mail